Alan’s practice focuses on the representation of biotech, pharma, medical device and other life sciences companies in connection with technology-driven strategic transactions. He advises companies on research collaborations and development agreements, intellectual property and technology licensing agreements, and commercial collaborations, including joint ventures, profit-sharing arrangements and co-promotion agreements. He also has experience with manufacturing, distribution, supply and quality agreements, clinical trial agreements, M&A transactions, and life sciences industry-specific matters and counseling.
In addition, Alan also brings more than 10 years of in-house experience, having worked at the pharmaceutical company Merck & Co., Inc. As counsel for corporate transactions at Merck, he worked closely with business development groups on biotech and pharma strategic transactions. Earlier at the company, he was responsible for successfully managing and resolving significant litigation and regulatory matters specific to the pharma and biotech industries.